if (have_posts()) : while (have_posts()) : the_post(); ?>
Strategic Assessment of the Multiple Sclerosis Market to Define Price and Access Potential for 4 Innovators in Emerging Markets Including South Africa

Value & Access

Strategic Assessment of the Multiple Sclerosis Market to Define Price and Access Potential for 4 Innovators in Emerging Markets Including South Africa

Project Scope

To conduct a strategic assessment to define price and access potential by mapping KOLs and payers through extensive primary and secondary research

UAE

UAE

Turkey

Turkey

SA

SA

KSA

KSA

Lebanon

Lebanon

Egypt

Egypt

Algeria

Algeria

Challenge

Our client was looking to understand KOLs and payer perceptions of 4 product profiles within RRMS to understand what the future treatment paradigm might look like and understand the associated pricing and access potential of their new asset

Solution

Mapping KOLs and payers, extensive primary & secondary research

  • Developed market landscape across market to set understanding of current treatment options, reimbursement status and cost of care
  • Conducted a mapping exercise to recruit top KOLs and payers for primary research
  • Conducted discussions with relevant stakeholders to understand value perceptions, price, reimbursement and access potential of four hypothetical products - tested various launch and sequencing scenarios

Results

  • Developed in depth landscape assessment across markets, understanding pricing and access pathways
  • Developed assessment of client product potential and provided pricing recommendations and supporting recommendations on how to differentiate the product vs. competitors and hence supporting associated messaging

Note: KOLs: Key Opinion Leaders, RRMS: Relapsing Remitting Multiple Sclerosis